Form D · Pharmaceuticals

EMISPHERE TECHNOLOGIES INC

Roseland, NJ · CIK 0000805326

Offering snapshot reported May 14, 2013 · SEC filing

Reported sold
$35.2M
Offering amount: $35.2M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 7, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 14, 2013Initial$35,168,880No comparison4SEC filing
Jul 19, 2011Initial$7,499,964No comparison16SEC filing
Sep 8, 2010Initial$7,065,006No comparison10SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-196433
The above amount equals the aggregate principal amount of convertible notes evidencing restructured debt of the issuer. In connection therewith, the issuer also issued warrants to purchase 21,997,776 shares of common stock at an exercise price of $0.50.

Source: Form D, filed May 14, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael R. Garone Executive
John D. Harkey Director
Timothy Mc Inerney Director
Michael Novinski Director, Executive
Jacob M. Plotsker Director
Mark H. Rachesky Director
Timothy G. Rothwell Director
Alan L. Rubino Director, Executive
Michael Weiser Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
4 Becker Farm Road, Suite 103
Roseland, NJ, 07068